Canada has approved the first oral COVID-19 treatment that can be taken at home. The drug, an antiviral developed by Pfizer, was found to reduce risk of hospitalization and death by 89 percent in clinical trials. At the moment, there is a “limited global supply” of the drug, thus Canadian health officials have prioritized the
Earlier this year, we reported on the positive findings of a Covid-19 treatment study, conducted by lead study author and JoinAStudy Investigator Dr. Anil Gupta. We are now proud to highlight that as of November 18, 2021 this research has been published in the prestigious New England Journal of Medicine. It is among the most reputable peer-reviewed medical
New research conducted by the University of Oxford in partnership with several American institutions has revealed a potential cause of endometriosis and a nonhormonal drug target that may lead to improved therapy for this condition. Endometriosis is when the kind of tissue that normally lines the uterus grows somewhere else. It can grow on the ovaries,
Analysis of data from 6.2 million people has found no significant associations between mRNA COVID-19 vaccines and serious side effects. The study authors, based in cities across the United States, undertook this study to compare mRNA vaccines’ negative effects in the first 21 days post-vaccination to negative effects occurring 22 days + after vaccination. Safe and
New research is shining light on the ugly side of the cosmetics industry. A peer-reviewed study published last month in Environmental Science and Technology presented evidence that hundreds of makeup products contain “high” levels of organic fluorine. This is an indicator that they also contain per- and polyfluoroalkyl substances (PFAS), which are known more colloquially
Swiss and Italian scientists have been able to prove a correlation between gut microbiota and the appearance of amyloid plaques in the brain, buildups typically associated with Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia and is an incurable condition that directly affects millions of people, and indirectly affects many more family
New research suggests that COVID-19 lockdowns led to 95,000 fewer air pollution-related deaths globally. Business closures and stay-at-home orders were the main drivers behind up to a 50% reduction in airborne concentrations of nitrogen dioxide, a direct emission from vehicles and coal-powered electricity plants. The greatest reduction in microscopic particulate matter released into the air
UPDATE 28/10/2021 Dr. Gupta’s work as lead researcher on this study has been published in The New England Journal of Medicine, in an article titled Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. You can find a link to the article on The Journal‘s website, here: https://www.nejm.org/doi/full/10.1056/NEJMoa2107934?query=featured_home UPDATE 30/8/2021 Dr. Gupta has given two
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!
The Food and Drug Administration (FDA) of the United States of America has recently issued a statement, updating Research Sites, Investigators, and IRBs on how best to deal with the ongoing challenges posed by COVID-19. These guidelines will help ensure the safety of trial participants, compliance with good clinical practice (GCP), and minimizing risks to
